(Total Views: 737)
Posted On: 04/29/2024 5:04:41 PM
Post# of 154603
Quote:
Once we publish, maybe we'll start getting some grants like this.
Their drug bezisterim selectively inhibited pro-inflammatory ERK/NK-kB signaling. All of which are on the leronlimab regulator list and downregulated. You have to wonder how drug companies catch the eye of the DoD, NIH or other federal agencies.
(6)
(0)
